Stanley C. Erck, Director at MAXCYTE, INC. (MXCT), sold 95,378 shares at $4.10 ($383K) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Scheduled sale ($383k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.10 | 17,922 | $73K | 19.2% |
| 2 | $4.10 | 17,922 | $73K | 19.2% |
| 3 | $3.97 | 29,767 | $118K | 30.8% |
| 4 | $3.97 | 29,767 | $118K | 30.8% |
| Total | $4.02 avg | 95,378 | $383K | 100% |
| Filing → |
| MXCT | SELL | 2024-10-02 | $358K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |
| NVAX | SELL | 2021-10-05 | $12.4M | — | Filing → |